Frequency of HLA-DRB1 gene alleles in patients with multiple sclerosis in a Lithuanian population

Medicina (Lithuania)

Volumn 48, Issue 1, 2012, Pages 9-14

  Balnyte, Renata ^a   Rastenyte, Daiva ^a   Mickevičiene, Dalia ^a   Vaitkus, Antanas ^a   Skrodeniene, Erika ^a   Vitkauskiene, Astra ^a  

^a LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

Author keywords

Case control study; Heterozygous inheritance; Homozygous inheritance; Human leukocyte antigen; Multiple sclerosis

Indexed keywords

HLA DRB1 ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE; HUMAN; LITHUANIA; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS;

ADOLESCENT; ADULT; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HLA-DRB1 CHAINS; HUMANS; LITHUANIA; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; YOUNG ADULT;

EID: 84861474410     PISSN: 1010660X     EISSN: None     Source Type: Journal    
DOI: 10.3390/medicina48010002     Document Type: Article

References (38)

1. Oksenberg JR, Baranzini SE. Multiple sclerosis genetics - is the glass half full, or half empty? Nat Rev Neurol 2010; 6:429-37.
2. Adomaitienė D, Janulevičiūtė N, Kazakevičius R, Vaičiuvėnas V. Klinikinės imunologijos ivadas. (Introduction to clinical immunology.) Kaunas: Šviesa; 2001. p. 112-24.
3. Handel AE, Handunetthi L, Giovannoni G, Ebers GC, Ramagopalan SV. Genetic and environmental factors and distribution of multiple sclerosis in Europe. Eur J Neurol 2010;17:1210-4.
4. Ramagopalan SV, Ebers GC. Multiple sclerosis: major histocompatibility complexity and antigen presentation. Genome Med 2009;1:105.
5. Schmidt H, Williamson D, Ashley-Koch A. HLA-DR15 haplotype and multiple sclerosis: a HuGe review. Am J Epidemiol 2007;165:1097-109.
6. Kaimen-Maciel DR, Reiche EMV, Borelli SD, Morimoto KH, Melo FC, Lopes J, et al. HLA-DRB1 allele-associated genetic susceptibility and protection against multiple sclerosis in Brazilian patients. Mol Med Report 2009;2:993-8.
7. Patrucco L, Larriba J, Redal MA, Rojas JI, Argibay PF, Cristiano E. HLA-DRB1 and multiple sclerosis in Argentina. Eur J Neurol 2009;16:427-9.
8. Wu JS, Qui W, Castley A, James I, Joseph J, Christiansen FT, et al. Presence of CSF oligoclonal bands (OCB) is associated with the HLA-DRB1 genotype in a West Australian multiple sclerosis cohort. J Neurol Sci 2010;288:63-7.
9. Marrosu MG, Murru R, Murru MR, Costa G, Zavattari P, Whalen M, et al. Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia. Hum Mol Genet 2001;10:2907-16.
10. Ballerini C, Guerini FR, Rombola G, Rosati E, Massacesi L, Ferrante P, et al. HLA-multiple sclerosis association in continental Italy and correlation with disease prevalence in Europe. J Neuroimmunol 2004;150:178-85.
11. Kwon OJ, Karni A, Israel S, Brautbar C, Amar, Meiner Z, et al. HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi Jews. Arch Neurol 1999;56: 555-60.
12. Dyment AD, Ebers G, Sadovick DA. Genetics of multiple sclerosis. Lancet Neurol 2004;3:104-10.
13. Ramagopalan VS, Dobson R, Meier CU, Giovannoni G. Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol 2010;9:727-39.
14. Ebers GC, Sadovnick AD, Dyment DA, Yee IM, Willer CJ, Risch N. Parent-of-origin effect in multiple sclerosis: observations in half-siblings. Lancet 2004;363:1773-4.
15. Polman CH, Reingold SC, Edan G. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald criteria". Ann Neurol 2005;6:840-6.
16. Celesia GG, Brigell MG. Recommended standards for pattern electroretinograms and visual evoked potentials. In: Deuschl G, Eisen A, editors. Recommendations for the practice of clinical neurophysiology: guidelines of the International Federation of Clinical Physiology (EEG, suppl 52). Elsevier science; 1999.
17. Siritho S, Freedman MS. The prognostic significance of cerebrospinal fluid in multiple sclerosis. J Neurol Sci 2009; 279:21-5.
18. Freedman MS, Thompson EJ, Deisenhammer F, Giovannoni G, Grimsley G, Keir G, et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis. Arch Neurol 2005;62:865-70.
19. Masterman T, Ligers A, Olsson T, Andersson M, Olerup O, Hillert J. HLA-DR15 is associated with lower age at onset in multiple sclerosis. Ann Neurol 2000;48:211-9.
20. Smestad C, Brynedal B, Jonasdottir G, Lorentzen AR, Masterman T, Akesson E, et al. The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients. Eur J Neurol 2007;14: 835-40.
21. Romero-Pinel L, Pujal JM, Martinez-Yelamos S, Gubieras L, Matas E, Bau L, et al. HLA DRB1: genetic susceptibility and disability progression in a Spanish multiple sclerosis population. Eur J Neurol 2011;18:337-42.
22. Silva AM, Pereira C, Bettencourt A, Carvalho C, Couto AR, Leite MI. The role of HLA DRB1 alleles on susceptibility and outcome of a Portuguese multiple sclerosis population. J Neurol Sci 2007;258:69-74.
23. Kouri I, Papakonstantinou S, Bempes V, Vasiliadis HS, Kyritsis AP, Pelidou HS. HLA associations with multiple sclerosis in Greece. J Neurol Sci 2011;308:28-31.
24. Dean G, Yeo TW, Goris A, Taylor AJ, Goodmann RS, Elian M, et al. HLA-DRB1 and multiple sclerosis in Malta. Neurology 2008;70:101-5.
25. Dyment DA, Herrera BM, Cader MZ, Willer CJ, Lincoln MR, Sadovnick AD, et al. Complex interaction among MHC haplotypes in multiple sclerosis: susceptibility and resistance. Hum Mol Genet 2005;14:2019-26.
26. Cree CAB, Reich ED, Khan O, De Jager PL, Nakashima I, Takahashi T, et al. Modification of multiple sclerosis phenotypes by African ancestry at HLA. Arch Neurol 2009; 66:226-33.
27. Stankovich J, Butzkueven H, Marriott M, Chapman C, Tubridy N, Tait BD, et al. HLA DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis. Tissue Antigens 2009;74:17-21.
28. Ghabaee M, Bayati A, Saroukolaei AS, Sahraian MA, Sanaati MH, Karimi P, et al. Analysis of HLA DR2&DQ6 (DRB1*1501, DQA1*0102, DQB1*0602) haplotypes in Iranian patients with multiple sclerosis. Cell Mol Neurobiol 2009;29:109-14.
29. Pandit L. Insights into the changing perspectives of multiple sclerosis in India. Autoimmune Dis 2011;5:1-5.
30. Fernandez O, R-Antiguedad A, Pinto-Medel MJ, Mendible MM, Acosta N, Oliver B, et al. HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain). J Neurol 2009;256:1977-88.
31. DeLuca GC, Ramagopalan SV, Herrera BM, Dyment DA, Lincoln MR, Montpetit A, et al. An extreme of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA DRB1 locus. Proc Natl Acad Sci U S A 2007;52:20896-901.
32. Weatherby SJM, Thomson W, Pepper L, Donn R, Worthington J, Mann CLA, et al. HLA DRB1 and disease outcome in multiple sclerosis. J Neurol 2001;248:304-10.
33. Hensiek AE, Sawcer SJ, Feakes R, Deans J, Mander A, Akesson E, et al. HLA-DR15 is associated with female sex and younger age at diagnosis in multiple sclerosis. J Neurol Neurosurg Psychiatry 2002;72:184-7.
34. Greer JM, McCombe P. Role of gender in multiple sclerosis: clinical effects and potential molecular mechanisms. J Neuroimmunol 2011;234:7-18.
35. Herrera BM, Ramagopalan SV, Orton S, Chao MJ, Yee IM, Sadovnick AD, et al. Parental transmission of MS in a population-based Canadian cohort. Neurology 2007;69: 1208-12.
36. Kantarci OH, Barcellos LF, Atkinson EJ, Ramsay PP, Lincoln R, Achenbach SJ, et al. Men transmit MS more often to their children vs women: the Carter effect. Neurology 2006;67:305-10.
37. Ramagopalan SV, Herrera BM, Bell JT, Dyment DA, Deluca GC, Lincoln MR, et al. Parental transmission of HLA DRB1*15 in multiple sclerosis. Hum Genet 2008;122:661-3.
38. Chao MJ, Barnardo MCN, Lincoln MR, Ramagopalan SV, Herrea BM, Dyment DA, et al. HLA class I alleles tag HLA DRB1*1501 haplotypes for differential risk in multiple sclerosis susceptibility. Proc Natl Acad Sci U S A 2008;35:13069-74.